Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas E Joshua

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|October 6, 2005
Multiple myeloma: the present and the futureDouglas E Joshua
BMJ (Clinical Research Ed.)|January 7, 2012
Multiple myelomaDanny C Hsu, Peter Wilkenfeld, Douglas E Joshua
Clinical Lymphoma & Myeloma|October 16, 2008
Regulatory T cells and multiple myelomaDouglas E Joshua, Ross D Brown, P Joy Ho, et al.
The Medical Journal of Australia|April 24, 2019
Biology and therapy of multiple myelomaDouglas E Joshua, Christian Bryant, Caroline Dix, et al.
The Medical Journal of Australia|January 19, 2011
The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationRoss D Brown, Mark R Langshaw, Elaine J Uhr, et al.
American Journal of Hematology|January 25, 2006
Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?Silvia Ling, Douglas E Joshua, John Gibson, et al.
Leukemia & Lymphoma|February 15, 2012
Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trialP Joy Ho, Ross D Brown, Andrew Spencer, et al.
Frontiers in Immunology|March 12, 2021
Treg and Oligoclonal Expansion of Terminal Effector CD8<sup>+</sup> T Cell as Key Players in Multiple MyelomaDouglas E Joshua, Slavica Vuckovic, James Favaloro, et al.
Leukemia & Lymphoma|September 18, 2008
Presence of Hoechst low side populations in multiple myelomaYen S Loh, Suilin Mo, Ross D Brown, et al.
Leukemia & Lymphoma|October 21, 2003
Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopesDaniel M Y Szea, Ross D Brown, Shihong Yang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|October 6, 2005
Multiple myeloma: the present and the futureDouglas E Joshua
BMJ (Clinical Research Ed.)|January 7, 2012
Multiple myelomaDanny C Hsu, Peter Wilkenfeld, Douglas E Joshua
Clinical Lymphoma & Myeloma|October 16, 2008
Regulatory T cells and multiple myelomaDouglas E Joshua, Ross D Brown, P Joy Ho, et al.
The Medical Journal of Australia|April 24, 2019
Biology and therapy of multiple myelomaDouglas E Joshua, Christian Bryant, Caroline Dix, et al.
The Medical Journal of Australia|January 19, 2011
The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationRoss D Brown, Mark R Langshaw, Elaine J Uhr, et al.
American Journal of Hematology|January 25, 2006
Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?Silvia Ling, Douglas E Joshua, John Gibson, et al.
Leukemia & Lymphoma|February 15, 2012
Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trialP Joy Ho, Ross D Brown, Andrew Spencer, et al.
Frontiers in Immunology|March 12, 2021
Treg and Oligoclonal Expansion of Terminal Effector CD8<sup>+</sup> T Cell as Key Players in Multiple MyelomaDouglas E Joshua, Slavica Vuckovic, James Favaloro, et al.
Leukemia & Lymphoma|September 18, 2008
Presence of Hoechst low side populations in multiple myelomaYen S Loh, Suilin Mo, Ross D Brown, et al.
Leukemia & Lymphoma|October 21, 2003
Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopesDaniel M Y Szea, Ross D Brown, Shihong Yang, et al.
Pageof 3